Gorelov A.V., Andreeva I.V., Zakharenko S.M., Sinopalnikov A.I.
The use of probiotics containing a combination of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 strains: Meta-analysis of efficacy in the prevention of antibiotic-associated diarrhea and in Helicobacter pylori eradication therapy
|
№10 / 2023
|
Didigova R.T., Evloeva D.A., Ugurchieva P.O., Malsagova I.Ya., Khamhoeva F.M.-B., Bokova M.D.
Evaluation of the efficacy of probiotic medicines including in the therapy of patients with post-infectious irritable bowel syndrome after COVID-19 infection surviving
|
№2 / 2023
|
Malyavin A.G., Gorelov A.V., Esaulenko E.V., Kalyuzhin O.V., Shikh E.V., Babak S.L., Pchelintsev M.V.
Consensus of the experts of the round table «ARVI therapy in adults: traditional concepts and prospects»
|
№10 / 2022
|
Grinevich V.B., Kravchuk Yu.A., Egorov D.V., Ivanyuk E.S., Plisikova N.A.
Clinical effectiveness of the probiotic containing B. longum, B. breve, L. rhamnosus, L. acidophilus in the treatment of irritable bowel syndrome with diarrhea
|
№7 / 2022
|
Trukhan D.I., Viktorova I.A., Ivanova D.S.
Diarrheas syndrome in real clinical practice: topical aspects of differential diagnostics and correction
|
№2 / 2020
|
S.D. Podymova
Irritable bowel syndrome
|
№2 / 2018
|
V.A. Akhmedov, I.N. Orlov, O.V. Gaus
Modern methods of rehabilitation of patients with irritable bowel syndrome
|
№3 / 2017
|
A.A. Ploskireva
Antibiotic-associated diarrhea: issues of therapeutic practice
|
№3 / 2016
|
M.A. Osadchuk, D.V. Balashov, M.M. Osadchuk
The use of probiotics in the practice of a therapist
|
№2 / 2016
|